ABCL 424B5: Secondary offering
AbCellera Biologics Inc.
Filed with the SEC on · accession 0001193125-26-344944
ABCL filed a 424B5 (prospectus (offering)) with the SEC on Aug 11, 2026. AbCellera Biologics Inc. filed a preliminary prospectus supplement for a $200,000,000 offering of common shares and pre-funded warrants to purchase common shares, with Jefferies, J.P. The stock moved +4.5% by the first close after the filing.
Summary of the filing
AbCellera Biologics Inc. filed a preliminary prospectus supplement for a $200,000,000 offering of common shares and pre-funded warrants to purchase common shares, with Jefferies, J.P. Morgan, Cantor, UBS Investment Bank, and BMO Capital Markets acting as underwriters.
Key details
How ABCL stock reacted
Close before
$9.34
Aug 10, 2026
First close after
+4.50%
$9.76
5 trading days
+19.91%
$11.20
Since filing
+33.83%
$12.50
✦ Ask GOAX AI about this filing — what it means for ABCL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ABCL?
Click hereFrequently asked questions
What did ABCL file with the SEC on Aug 11, 2026?
ABCL filed a 424B5 (Secondary offering). AbCellera Biologics Inc. filed a preliminary prospectus supplement for a $200,000,000 offering of common shares and pre-funded warrants to purchase common shares, with Jefferies, J.P. Morgan, Cantor, UBS Investment Bank, and BMO Capital Markets acting as underwriters.
What does a secondary offering mean for ABCL stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did ABCL stock react to this filing?
ABCL closed at $9.34 before the filing and $9.76 on Aug 11, 2026 (+4.50%). Five trading days later: $11.20 (+19.91%).
Other ABCL SEC filings
- 8-K · SEC filingNov 9, 2026
- 8-K · Secondary offeringAug 13, 2026
- 424B5 · Secondary offeringAug 13, 2026
- 8-K · Fda approvalAug 10, 2026
- 8-K · Fda approvalAug 7, 2026
- 8-K · SEC filingAug 5, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · Material agreementJul 29, 2026
- 8-K · Board changeJul 6, 2026
- 8-K · Material agreementJun 17, 2026
Get alerts when ABCL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days